首页 | 本学科首页   官方微博 | 高级检索  
     

受血者受血前HIV、HBV、 HCV、梅毒感染及其重叠感染研究
引用本文:刘仕莲,池雷霆,吴林伯,姚蓉玲,黄德全,彭双林. 受血者受血前HIV、HBV、 HCV、梅毒感染及其重叠感染研究[J]. 中国感染控制杂志, 2009, 8(2): 110-112
作者姓名:刘仕莲  池雷霆  吴林伯  姚蓉玲  黄德全  彭双林
作者单位:1. 达州市中心医院,四川,达州,635000
2. 四川大学华西医院,四川,成都,610041
摘    要:目的研究受血者受血前人免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、梅毒感染及其重叠感染现状与特点。方法对2007年10月-2008年6月间某院需输注血制品的9694例患者进行检测;采用酶联免疫吸附试验检测血清HBV标志物、血清抗HCV,双抗原夹心酶联免疫法检测血清抗HIV和梅毒抗体。结果9694例受血者受血前血清HBV标志物阳性1549例(15.98%),抗HCV阳性59例(0.61%),抗HIV阳性34例(0.35%),梅毒抗体阳性495例(5.11%)。重叠感染者中,HBV与HCV57例(0.59%),HBV与梅毒94例(0.97%),HCV与梅毒3例(0.03%);血清抗HIV阳性患者中,重叠感染HBV13例(0.13%),HCV10例(0.10%),梅毒4例(0.04%);HIV、HBV和HCV重叠,HIV、HBV和梅毒重叠感染各2例(1.08%),HIV、HBV、HCV和梅毒重叠感染1例(0.54%)。结论部分受血者在受血前就已有感染,特别是HBV和梅毒的感染率较高。对受血者于受血前进行全面检查不仅可避免相关医疗纠纷,还可为患者治疗和医务人员的职业防护提供帮助。

关 键 词:输血  受血者  血传播疾病  肝炎病毒  乙型  肝炎病毒  丙型  人免疫缺陷病毒  梅毒  重叠感染
收稿时间:2008-10-21
修稿时间:2008-12-23

Infection and co-infection of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis in recipients before transfusion
LIU Shi lian,CHI Lei ting,WU Lin bo,YAO Rong ling,HUANG De quan,PENG Shua. Infection and co-infection of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis in recipients before transfusion[J]. Chinese Journal of Infection Control, 2009, 8(2): 110-112
Authors:LIU Shi lian  CHI Lei ting  WU Lin bo  YAO Rong ling  HUANG De quan  PENG Shua
Affiliation:1. The Central Hospital of Dazhou, Dazhou 635000, China; 2. Huaxi Hospital of Sichuan University ,Chengdu 610041, China)
Abstract:Objective To investigate the condition and characteristics of infection and co-infection of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis before transfusion. Methods 9 694 cases of transfusing recipients in a hospital between October, 2007 and June, 2008 were detected; Serum HBV markers, anti-HCV were detected by enzyme linked immunosorbent assay (ELISA) ; Serum anti-HIV, anti-syphilis were detected by double-sandwich ELISA(DS-ELISA). Results Among 9 694 transfusing recipients, the positive rate of HBV marker before receiving transfusion was 15.98% (1 549 cases), the positive rate of anti- HCV, anti-HIV and anti-syphilis was 0. 61% (59 cases), 0. 35% (34 cases) and 5.11% (495 cases) respectively. The co-infection rate of HBV and HCV was 0. 59% (57 cases), the co-infection rate of HBV and syphilis was 0. 97% (94 cases), the co-infection rate of HCV and syphilis was 0. 03% (3 cases) ; Among patients with HIV positive, the co-infection rate with HBV, HCV and syphilis was 0. 13%(13 cases), 0. 10%(10 cases) and 0. 04% (4 cases) respectively; The co-infection rate of HIV, HBV and HCV was 1. 08% (2 cases), the co-infection rate of HIV, HBV and syphilis was 1.08%(2 cases), co-infection rate of HIV, HBV, HCV and syphilis was 0. 54%(1 case). Conclusion Some recipients have infection before transfusion, especially HBV and syphilis infection. The over-all examination on recipients not only can avoid medical dispute, but also improve clinical therapy for patients and health care workers occupation safety protection.
Keywords:transfusion  recipients  blood-transmitted diseases  hepatitis B virus  hepatitis C virus  human immunodeficiency virus  syphilis  co-infection
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号